Nosopharm Signs Partnership With Inrae and University of Montpellier to Develop New Anti-Infectives
Lyon, France, March 15, 2022—Nosopharm, specialized in exploring
unconventional sources of antibiotics to discover new drugs to fight
antimicrobial resistance, today announces that it has signed a
collaboration agreement with the DGIMI laboratory (UMR1333: Diversity,
Genomes and Insects-Microorganisms Interactions). DGIMI falls under
the authority of the French National Research Institute for Agriculture,
Food, and the Environment (INRAE) and the University of Montpellier.
The aim of this collaboration is to produce chemical libraries of new
bioactive molecules which will feed into Nosopharm’s anti-infective
screening campaigns against antibiotic resistance. ‘France Relance’, the
French government investment plan created following the Covid-19
pandemic, brings financial support to this new collaboration between
Nosopharm, INRAE and University of Montpellier.
More info >> |